Actuate Therapeutics (ACTU) Change in Cash (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Change in Cash of -$3.8 million for Q4 2025, up 22.87% year-over-year from -$3.1 million in Q4 2024, and down 136.09% quarter-over-quarter from $10.4 million in Q3 2025.
Actuate Therapeutics (ACTU) Change in Cash (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Change in Cash for 3 consecutive years, with -$3.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Cash rose 22.87% year-over-year to -$3.8 million; the TTM figure through Dec 2025 stood at $4.5 million (down 20.5% YoY), while the FY2025 annual figure was $4.5 million, down 20.5% from the prior year.
- Change in Cash declined to -$3.8 million in Q4 2025 per ACTU's latest filing, from $10.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $13.2 million in Q3 2024 and bottomed at -$5.6 million in Q3 2023.
- Historically, Change in Cash has averaged -$94933.1 across 3 years, with a median of -$2.7 million in 2024.
- Annual changes were most pronounced in 2024 — Change in Cash soared 333.61% — and 2025, when it slumped 433.75%.
- Actuate Therapeutics' Change in Cash stood at -$5.5 million in 2023, then climbed by 11.43% to -$4.9 million in 2024, then gained by 22.87% to -$3.8 million in 2025.
- Business Quant data shows ACTU's Change in Cash at -$3.8 million in Q4 2025, $10.4 million in Q3 2025, and $2.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.77 Mn |
| Sep 30, 2025 | 10.43 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | -4.75 Mn |
| Dec 31, 2024 | -4.88 Mn |
| Sep 30, 2024 | 13.17 Mn |
| Jun 30, 2024 | -1.72 Mn |
| Mar 31, 2024 | -890,352.00 |
| Dec 31, 2023 | -5.51 Mn |
| Sep 30, 2023 | -5.64 Mn |